Sinochem

Sinochem operates as a major Chinese pharmaceutical company with global reach. It integrates trade, R&D, manufacturing, and distribution of APIs, intermediates, finished formulations, medical devices and nutritional ingredients. Its research arm has developed innovative small molecule drugs such as SYD007 for bladder infusion therapy. The company holds leading market positions in export of chondroitin/glucosamine for bone/joint health and stevia sweetener. It maintains FDA/GMP certifications for international supply chains. Clinical results or trial data are generally not published due to its B2B/export focus rather than direct-to-market novel therapeutics.